We are live on
!
Find out more
JO
John Overdeck Two Sigma Investments
AUM
$138B
1-Year Est. Return
41.87%
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
This Fund
S&P 500
This Quarter
Est. Return
+9.41%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$36.7B
AUM Growth
+$3.15B
(+9.4%)
Cap. Flow
+$935M
Cap. Flow
% of AUM
2.55%
Top 10 Holdings %
Top 10 Hldgs %
5.15%
Holding
3,891
New
644
Increased
1,079
Reduced
1,381
Closed
771
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$159M |
| 2 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$156M |
| 3 |
Intel
INTC
|
+$140M |
| 4 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$125M |
| 5 |
Carnival Corporation Ltd
CCL
|
+$124M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Burlington
BURL
|
+$168M |
| 2 |
ABMD
Abiomed Inc
ABMD
|
+$160M |
| 3 |
Meta Platforms (Facebook)
META
|
+$147M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$142M |
| 5 |
Baidu
BIDU
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.13% |
| 2 | Consumer Discretionary | 12.6% |
| 3 | Industrials | 10.86% |
| 4 | Healthcare | 10.49% |
| 5 | Financials | 10.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3026
Syndax Pharmaceuticals
SNDX
$1.75B
| $186K | ﹤0.01% |
+23,065
| New | +$164K |
|
3027
Canadian Solar
CSIQ
$972M
| $184K | ﹤0.01% |
+12,693
| New | +$175K |
|
3028
Sabesp
SBS
$16.3B
| $181K | ﹤0.01% |
158,388
+41,768
| +36% | +$50.9K |
|
|
ACHN
3029
DELISTED
Achillion Pharmaceuticals
ACHN
| $179K | ﹤0.01% |
48,703
-126,519
| -72% | -$377K |
|
3030
Cytosorbents Corp
CTSO
$23.9M
| $177K | ﹤0.01% |
13,702
-178,231
| -93% | -$2.23M |
|
3031
Hope Bancorp
HOPE
$1.78B
| $177K | ﹤0.01% |
10,949
-22,161
| -67% | -$384K |
|
|
PFIE
3032
DELISTED
Profire Energy, Inc
PFIE
| $177K | ﹤0.01% |
55,600
+3,352
| +6% | +$10.7K |
|
3033
Hallador Energy
HNRG
$752M
| $176K | ﹤0.01% |
28,361
-56,940
| -67% | -$360K |
|
3034
Lantheus
LNTH
$6.58B
| $172K | ﹤0.01% |
11,500
-12,796
| -53% | -$187K |
|
|
MCBC
3035
DELISTED
Macatawa Bank Corp
MCBC
| $172K | ﹤0.01% |
14,652
-8,822
| -38% | -$109K |
|
3036
ICL Group
ICL
$7.42B
| $169K | ﹤0.01% |
28,028
-46,936
| -63% | -$249K |
|
3037
CALL
Transocean
RIG
$6.46B
| $169K | ﹤0.01% |
12,100
-247,400
| -95% | -$3.07M |
|
|
HSTO
3038
DELISTED
Histogen Inc. Common Stock
HSTO
| $168K | ﹤0.01% |
+145
| New | +$134K |
|
|
ONCT
3039
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $164K | ﹤0.01% |
+745
| New | +$1.79M |
|
3040
Fidus Investment
FDUS
$753M
| $163K | ﹤0.01% |
11,142
-31,209
| -74% | -$460K |
|
|
ALNA
3041
DELISTED
Allena Pharmaceuticals
ALNA
| $162K | ﹤0.01% |
15,080
-13,201
| -47% | -$145K |
|
|
HDSN
3042
Hudson Technologies
HDSN
$233M
| $159K | ﹤0.01% |
124,564
-15,001
| -11% | -$26.6K |
|
3043
Radcom
RDCM
$171M
| $158K | ﹤0.01% |
14,019
-3,818
| -21% | -$69.5K |
|
3044
Allot
ALLT
$369M
| $157K | ﹤0.01% |
25,348
-200
| -0.8% | -$1.17K |
|
|
KA
3045
DELISTED
Kineta, Inc. Common Stock
KA
| $156K | ﹤0.01% |
463
-221
| -32% | -$78.8K |
|
3046
PUT
Kratos Defense & Security Solutions
KTOS
$9.96B
| $154K | ﹤0.01% |
+10,400
| New | +$137K |
|
3047
Babcock & Wilcox
BW
$1.15B
| $153K | ﹤0.01% |
14,833
+1,577
| +12% | +$26.2K |
|
|
RRTS
3048
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $149K | ﹤0.01% |
7,129
-10,481
| -60% | -$466K |
|
3049
ING
ING
$100B
| $146K | ﹤0.01% |
11,228
-444,153
| -98% | -$6.23M |
|
3050
CALL
GoPro
GPRO
$111M
| $145K | ﹤0.01% |
20,200
-24,300
| -55% | -$155K |
|
Similar funds
John Overdeck's Q3 2018 Portfolio in Review
As of Q3 2018, John Overdeck held 3,891 positions worth $36.7B, up 9.4% from $33.5B the previous quarter. Its ten largest holdings account for 5.1% of the portfolio.
John Overdeck's Q3 2018 filing shows 644 new, 1,079 increased, 1,381 reduced and 771 closed positions. Its largest new stake was Royal Caribbean: 1,011,770 shares worth $131M. The largest sale was Burlington, an estimated $168M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Consumer Discretionary and Industrials.
- John Overdeck's largest Q3 2018 buy was Royal Caribbean: 1,011,770 shares worth $131M.
- John Overdeck added most to Boeing in Q3 2018, an estimated $159M increase.
- John Overdeck's biggest Q3 2018 reduction was Burlington, cutting an estimated $168M.
- John Overdeck fully exited Align Technology in Q3 2018, selling an estimated $116M.
- John Overdeck's ten largest holdings make up 5.1% of its $36.7B portfolio in Q3 2018.
- John Overdeck opened 644 new positions and closed 771 in Q3 2018.
- John Overdeck's portfolio value rose 9.4% quarter-over-quarter to $36.7B.
Based on Two Sigma Investments's 13F filing for Q3 2018, filed 14 Nov 2018.